OpenAlex
PricingAboutJobs
Log inGet started
Work

New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines

HTML

Year: 2019
Type: review
Source: Annals of Allergy Asthma & Immunology
DOI: 10.1016/j.anai.2019.10.005
Authors: Yael Renert-Yuval, Emma Guttman-Yassky
Institutions: Rockefeller University, Icahn School of Medicine at Mount Sinai
Language: English

Topic: Dermatology and Skin Diseases
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Keywords: atopic dermatitis, new drugs, JAK inhibitors, histamine H4 receptor antagonists, IL-4/IL-13 blockade, apremilast, phosphodiesterase-4 inhibitors, systemic therapy, moderate-to-severe atopic dermatitis
SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Pfizer, Merck, Novartis, Sanofi, Celgene, AbbVie, Regeneron Pharmaceuticals, UCB, Dermira, Asana Biosciences, Glenmark Pharmaceuticals, MedImmune, Galderma, LEO Pharma, Janssen Biotech
OpenAlex ID: W2980943823
FWCI: 3.723
Cites: 112
Cited by: 136
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security